Gene therapy milestone for sickle cell & Supreme Court upholds birthright citizenship - News (Jul 4, 2026)

A young man in Louisiana is being called the state’s first functional cure of sickle cell disease—after gene therapy, his doctors say the illness is no longer active, and it may even put a pilot’s license back within reach. Welcome to The Automated Daily, top news edition. The podcast created by generative AI. I’m TrendTeller, and today is July 4th, 2026. Here’s what’s making headlines—and why it matters.

Gene therapy milestone for sickle cell

We’ll start with health, because this is the kind of story that changes what people think is possible. A 23-year-old from Metairie, Louisiana, Daniel Cressy, has been reported as the first person in the state to be functionally cured of sickle cell disease through gene therapy. After years of preparation and treatment, doctors say the disease is no longer active in his system. In a state with the highest per-capita rate of sickle cell in the U.S., that’s not just a personal milestone—it’s a sign that gene-altering therapies are moving beyond a handful of trials and into real hospital programs, with real patients planning real futures.

Supreme Court upholds birthright citizenship

Sticking with medical breakthroughs, researchers at the University of Arizona say an experimental drug candidate called XL20 shows promise against ALS by targeting a central culprit seen in most cases: the protein TDP-43 going rogue and forming toxic clumps. What’s notable here is the approach—rather than trying to wipe out a protein the body actually needs, the drug aims to block the specific part that drives the damage. In early tests, it crossed the blood–brain barrier and helped in ALS mouse models, and it also showed encouraging signs in lab-grown human motor neurons. It’s still early-stage, but it’s the kind of result that can shape where the next wave of ALS drug development goes.

Micron expands Japan memory chip plant

Now to U.S. law and politics. The Supreme Court has struck down President Trump’s 2025 executive order that tried to deny citizenship to children born in the United States if their parents were temporarily or unlawfully present. The majority leaned on long-standing legal tradition and the public meaning of the 14th Amendment, reaffirming that birth on U.S. soil generally confers citizenship, with narrow historical exceptions. The takeaway is bigger than one case: the Court is signaling that changing birthright citizenship isn’t something an executive order can do—and that even Congress would run into constitutional limits unless the country is willing to revisit the Constitution itself.

Governments seek stakes in AI firms

Turning to the new shape of the AI economy—starting with the chips that power it. Micron has broken ground on a massive expansion of its Hiroshima factory in western Japan, aiming to produce advanced memory chips—especially high-bandwidth memory, or HBM, a key ingredient for AI accelerators used across the industry. Shipments are expected around summer 2028. Japan is backing the build with major subsidies, underscoring how semiconductors are now treated as strategic infrastructure, tied to both economic resilience and national security. For Micron, it’s part of a wider push to meet AI-driven demand, alongside major U.S. projects—because the race isn’t only about better models; it’s about who can supply the hardware at scale.

China’s Z.ai model pressures AI market

And as governments worry about who controls the most powerful AI systems, a different idea is gaining traction: partial ownership. Reports say U.S. officials and OpenAI have discussed the possibility of the government taking a small stake, while India is also considering a minority position in Bengaluru-based Sarvam AI, potentially linked to state-backed compute support. Nothing is final, but the shift is telling. Regulation can set boundaries; ownership can offer ongoing visibility, influence, and a claim on upside—especially as voters question who benefits from AI productivity and who bears the cost in jobs, misinformation, and concentration of power.

NATO reshuffles forces as US steps back

That competitive pressure is also coming from China. A Beijing startup called Z.ai has launched a new large language model, GLM-5.2, and it’s drawing attention outside China for strong performance at a relatively low price. Some analysts are calling it a “mini DeepSeek moment,” suggesting Chinese models are narrowing the gap in areas like coding and multi-step task completion. If that holds up, it could push AI costs down globally and make advanced tools accessible to more developers and companies—while also sharpening the geopolitical edge of AI, as restrictions on chips and markets collide with rapidly improving capability.

Sahel juntas move to quit ICC

On defense and alliances, NATO’s top military commander, U.S. General Alex Grynkewich, says European allies have largely replaced capabilities the United States recently pulled from NATO crisis-response planning. Washington had told allies it would no longer commit certain major assets—moves that surprised partners and forced NATO to look at backup options for a worst-case scenario. Grynkewich now says Europe moved quickly to fill many gaps, while NATO explores alternatives where the U.S. still has unique strengths. This will loom over the upcoming NATO summit in Turkey, because the real question isn’t only whether Europe can step up—it’s whether collective defense planning looks as credible on paper as it does in speeches.

Europe reels from early heatwaves

In West Africa’s Sahel region, Burkina Faso, Mali, and Niger have formally notified the United Nations they intend to withdraw from the International Criminal Court, with the exits set to take effect in a year. Their military-led governments argue the court is selective and politicized. Human rights groups see a different backdrop: rising allegations of mass civilian killings, arbitrary detentions, and crackdowns on dissent during counterinsurgency campaigns. Even if the ICC can still pursue crimes committed while the countries were members, leaving would narrow paths to accountability—and it adds to a broader pattern after the three states also left ECOWAS, further isolating the region from external legal pressure.

New ALS drug targets TDP-43

Now to the climate signal that’s hard to ignore. After two record-breaking heatwaves in May and June, the UK and parts of Europe are heading into early July with another surge expected. In the UK, provisional numbers show a new June high near 37.7 degrees Celsius, with an unusually large number of weather stations setting records—and the nights were a big part of the story, too, with sticky humidity and warm minimum temperatures becoming more common. Across Europe, several countries broke June records and some crossed 40 degrees, which is striking given June is usually less extreme than late summer. Scientists continue to link the rising frequency and intensity of these events to human-driven climate change, with Europe warming faster than many other regions.

NASA funds new lunar landers

Finally, to the Moon—where NASA is trying to learn faster by flying more often. The agency has awarded close to six hundred million dollars to three companies for four new lunar lander deliveries by late 2028. The idea is to send the same types of instruments to multiple sites, creating comparable measurements—less like a one-off stunt, more like building a reliable map of conditions and hazards. That kind of repeat data matters if you’re serious about sustained lunar operations, because the Moon is unforgiving, and “we think it’s safe” isn’t good enough when you’re planning long-term infrastructure.

That’s the Top News Edition for July 4th, 2026. If you’re tracking one theme across today’s stories, it’s this: countries are treating health, chips, AI, and security as strategic assets—and they’re acting like the stakes will compound over time. Thanks for listening. I’m TrendTeller, and this was The Automated Daily. Check back tomorrow for the next briefing.

Gene therapy milestone for sickle cell & Supreme Court upholds birthright citizenship - News (Jul 4, 2026)

Our Sponsors

Today's Top News Topics